🔎 Trials Near Me

Hjem › Demens › Massachusetts

Demens kliniske forsøg i Massachusetts

17 studier for Demens søger deltagere på steder i Massachusetts.

Byer i Massachusetts

Officiel studietekst (engelsk)

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  • Local Institution - 0080, Watertown
RekruttererFase 3
Alder 60 til 85 · Alle køn · Opdateret 17. sep. 2026 · NCT06976203

Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

  • Vitalix, Worcester
RekruttererFase 2
Alle aldre · Alle køn · Opdateret 16. sep. 2026 · NCT06052254

The BRAIN App (Phase 2 SBIR)

  • Hopeful Aging, Winchester
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06298474

Making Connections Thru Music

  • Hopeful Aging, Winchester
  • The Hearthstone Institute, LLC, Winchester
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 103 · Alle køn · Opdateret 15. sep. 2026 · NCT06079216

Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium

  • Massachusetts General Hospital, Boston
RekruttererObservationsstudie
Alder 70 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT06052397

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

  • VA Boston Healthcare System, Boston
RekruttererFase 4Frivillige med god helbredstilstand velkomne
Alder 75 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT04262206

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  • Massachusetts General Hospital (MGH), Charlestown
RekruttererFase 1
Alder 50 til 85 · Alle køn · Opdateret 24. aug. 2026 · NCT06297590

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  • Boston Center for Memory, Newton
RekruttererFase 3
Alder 60 til 85 · Alle køn · Opdateret 20. aug. 2026 · NCT06976216

Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome

  • Hebrew Rehabilitation Center, Roslindale
Rekrutterer
Alder 65 til 90 · Alle køn · Opdateret 16. jul. 2026 · NCT06821568

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • Boston Center for Memory, Newton
  • MedVadis Research Corporation, Waltham
RekruttererFase 3
Alder 55 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • ActivMed Practices and Research, Methuen
RekruttererFase 2
Alder 50 til 85 · Alle køn · Opdateret 26. jun. 2026 · NCT07094516

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • Massachusetts General Hospital, Co-Enrolling through ABC-DS Only, Boston
RekruttererObservationsstudie
Alder 25 til 55 · Alle køn · Opdateret 18. maj 2026 · NCT04165109

Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

  • Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston
RekruttererFase 2
Alder 60 til 85 · Alle køn · Opdateret 12. feb. 2026 · NCT06489548

Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia

  • Hinda and Arthur Marcus Institute for Aging Research, Boston
Rekrutterer
Alder 55 og opefter · Alle køn · Opdateret 12. jan. 2026 · NCT05661084

Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0

  • Hebrew SeniorLife, Boston
Rekrutterer
Alder 60 til 106 · Alle køn · Opdateret 6. jan. 2026 · NCT05950607

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

  • McLean Hospital, Belmont
RekruttererObservationsstudie
Alder 18 til 89 · Alle køn · Opdateret 6. nov. 2025 · NCT05245903

Assess Fibrin in Brains With AD/ADRD

  • Massachusetts General Hospital, Boston
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 55 til 90 · Alle køn · Opdateret 30. okt. 2025 · NCT05336695

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.